20 ILCS 2310/2310-362

Current through Public Act 103-1052
Section 20 ILCS 2310/2310-362 - [Renumbered from 20 ILCS 2310/2310-361] The Autoimmune Disease Research Fund
(a) The Autoimmune Disease Research Fund is created as a special fund in the State treasury. From appropriations to the Department from the Fund, the Department shall make grants to public and private entities in the State for the purpose of funding research for the treatment and cure of autoimmune diseases.
(b) For the purposes of this Section:

"Autoimmune disease" means any disease that results from an aberrant immune response, including, without limitation, rheumatoid arthritis, systemic lupus erythematosus, and scleroderma.

"Research" includes, without limitation, expenditures to develop and advance the understanding, techniques, and modalities effective in the detection, prevention, screening, and treatment of autoimmune disease and may include clinical trials. "Research" does not include institutional overhead costs, indirect costs, other organizational levies, or costs of community-based support services.

(c) Moneys received for the purposes of this Section, including, without limitation, income tax checkoff receipts and gifts, grants, and awards from any public or private entity, must be deposited into the Fund. Any interest earnings that are attributable to moneys in the Fund must be deposited into the Fund.

20 ILCS 2310/2310-362

Renumbered from 20 ILCS 2310/2310-361 by P.A. 095-0876,§ 60, eff. 8/21/2008.
Added by P.A. 095-0435,§ 5, eff. 8/27/2007.